Document is current
Any future updates will be listed below
-
Authors
Ciccarelli, Luciano https://orcid.org/0009-0004-5468-1021
Mahaux, Olivia https://orcid.org/0000-0002-9361-3118
Roshan, Christie https://orcid.org/0009-0006-5670-2767
Fofana, Ami https://orcid.org/0009-0007-3976-527X
Kawka, Anna https://orcid.org/0009-0004-1331-9528
Occhipinti, Emilia https://orcid.org/0009-0009-6621-5913
Possidente, Mariapia https://orcid.org/0009-0006-2784-1573
Cenci, Silvia https://orcid.org/0009-0002-4413-4468
Painter, Jeffery L. https://orcid.org/0000-0001-9651-9904
Bate, Andrew https://orcid.org/0000-0003-3151-3653
-
Funding
Funding for this research was provided by:
GSK
- License Information
-
More Information
Article History
Received: 13 April 2026
Accepted: 21 June 2026
First Online: 10 August 2026
Declarations
Conflict of Interest: All authors are/were employed by GSK at the time of study. OM, CR, SC, JLP, and AB hold financial equities in GSK. AB is an Editorial Board member of Drug Safety . AB was not involved in the selection of peer reviewers for the manuscript nor in any of the subsequent editorial decisions. The authors declare no other financial or non-financial relationships and activities.
Ethics Approval: Not applicable.
Consent to Participate: Not applicable.
Consent for Publication: Not applicable.
Availability of Data and Material: The data that support the findings of this study are available from the corresponding author (LC), upon reasonable request.
Code Availability: Not applicable.
Authors’ Contributions: LC, OM, CR, SC, JLP, and AB participated in study concept/design; OM was involved in data acquisition; LC, OM, CR, AF, AK, EO, and MP participated to data analysis. All authors took part in data interpretation. All authors read and approved the final version.Â
